WHO ICTRP trial
Study of the effect of gabapentin used as a preemptive to the emergence and…
EUCTR2016-002177-35-CZ · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-002177-35-CZ |
|---|---|
| Public title | Study of the effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma |
| Scientific title | The effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma - GabaNeuBol |
| Primary sponsor | Masarykova univerzita |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Czech Republic |
| Conditions | Chronic neuropathic pain in patients after spinal cord trauma;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] |
| Interventions | Pharmaceutical Form: Capsule, hard INN or Proposed INN: Gabapentinum Other descriptive name: GABAPENTIN Concentration unit: mg milligram(s) Pharmaceutical Form: Tablet INN or Proposed INN: Metamizole Sodium CAS Number: 68-89-3 Other… |
| Registration date | Jan 18, 2017 |
| Target size | 120 |
| Secondary IDs | GNB-2015 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: